All In Biotech

Drug Trial Radar · NCT06911567

A Study to Assess New Formulations of TEV-56286

An Open-Label, Randomized, Crossover Study to Assess the Comparative Bioavailability of New TEV-56286 Formulations Compared to a Reference TEV-56286 Capsule Formulation Following Single-Dose Administration in Healthy Participants

Last checked: Nov 19, 2026Latest source record: Feb 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

47

Actual

Start

Mar 10, 2025

Primary completion

May 22, 2025

Study completion Jun 2, 2025

Sponsor

Sponsor type
Industry
First posted
Apr 4, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of the study is to assess the relative bioavailability of TEV-56286 test formulations compared to TEV-56286 reference product in healthy adult participants. The secondary objective is to evaluate the safety and tolerability of TEV-56286. The planned duration for each participant is approximately 70 days which includes a 45 day screening period.

Conditions

  • Healthy Participants

Interventions

  • TEV-56286 TestDrug

    Administered orally

  • TEV-56286 ReferenceDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Observed Drug Concentration (Cmax)Time frame: Up to Day 17
  2. Area Under the Drug Concentration-Time Curve from Time 0 to Last Measurable Drug Concentration [AUC(0-t)]Time frame: Up to Day 17
  3. Area Under the Drug Concentration-Time Curve from Time 0 to Infinity [AUC(0-inf)]Time frame: Up to Day 17

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Teva Investigational Site 12141

    Miramar, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.